FlowCytomix analysis for Toxoplasma gondii infection in pregnant women in central Taiwan

Journal of Obstetrics and Gynaecology

Volumn 31, Issue 5, 2011, Pages 375-379

  Chou, C S ^a   Lin, L Y ^a   Chen, K M ^a   Lai, S C ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cytokine; pregnant; T. gondii; Taiwan

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BINDING AFFINITY; BLOOD SAMPLING; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PREGNANT WOMAN; PRIORITY JOURNAL; SEROPREVALENCE; TAIWAN; TH1 CELL; TH2 CELL; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ANIMALS; CATS; CYTOKINES; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES; TAIWAN; TOXOPLASMA; TOXOPLASMOSIS;

EID: 79957825232     PISSN: 01443615     EISSN: 13646893     Source Type: Journal    
DOI: 10.3109/01443615.2011.568073     Document Type: Article

References (40)

1. Alexander J, Jebbari H, Bluethmann H, Brombacher F, Roberts CW. 1998. The role of IL-4 in adult acquired and congenital toxoplasmosis. International Journal for Parasitology 28:113-120. (Pubitemid 28082064)
2. Bohne W, Heesemann J, Gross U. 1993. Induction of bradyzoite specific Toxoplasma gondii antigens in gamma-interferon-treated mouse macrophages. Infection and Immunity 61:1141-1145. (Pubitemid 23059681)
3. Candolfi E, Hunter CA, Remington JS. 1995. Role of gamma interferon and other cytokines in suppression of the spleen cell proliferative response to Concanavalin A and toxoplasma antigen during acute toxoplasmosis. Infection and Immunity 63:751-756.
4. Chen M, Mun HS, Piao LX, Aosai F, Norose K, Mohamed RM et al. 2003. Induction of protective immunity by primed B-1 cells in Toxoplasma gondii-infected B cell-deficient mice. Microbiology and Immunology 47:997-1003. (Pubitemid 38019919)
5. Denkers EY, Gazzinelli RT. 1998. Regulation of function of T-cellmediated immunity during Toxoplasma gondii infection. Clinical Microbiology Reviews 11:569-588. (Pubitemid 28497562)
6. Filisetti D, Candolfi E. 2004. Immune response to Toxoplasma gondii. Annali Dell'Istituto Superiore di Sanità 40:71-80. (Pubitemid 39310674)
7. Gazzinelli RT, Denkers EY, Sher A. 1993. Host resistance to Toxoplasma gondii: model for studying the selective induction of cell-mediated immunity by intracellular parasites. Infectious Agents and Disease 2:139-149. (Pubitemid 23352907)
8. Handman E, Remington JS. 1980. Antibody responses to toxoplasma antigens in mice infected with strains of different virulence. Infection and Immunity 29:215-220. (Pubitemid 10085998)
9. Hedman K, Lappalainen M, SeppäiäI, MäkeläO.1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. Journal of Infectious Diseases 159:736-740. (Pubitemid 19105628)
10. Heinzel FP, Sadick MD, Holaday BJ, Coffman RL, Locksley RM. 1989. Reciprocal expression of interferon gamma or interleukin 4 during the resolution or progression of murine leishmaniasis. Evidence for expansion of distinct helper T cell subsets. Journal of Experimental Medicine 169:59-72. (Pubitemid 19035542)
11. Hunter CA, Abrams JS, Beaman MH, Remington JS. 1993. Cytokine mRNA in the central nervous system of SCID mice infected with Toxoplasma gondii: importance of T-cell-independent regulation of resistance to T. gondii. Infection and Immunity 61:4038-4044. (Pubitemid 23298551)
12. Hunter C, Candolfi E, Subauste C, van Cleave V, Remington J. 1995. Studies on the role of interleukin-12 in acute murine toxoplasmosis. Immunology 84:16-20.
13. Jenum PA, Stray-Pedersen B, Gundersen AG. 1997. Improved diagnosis of primary Toxoplasma gondii infection in early pregnancy by determination of antitoxoplasma immunoglobulin G avidity. Journal of Clinical Microbiology 35:1972-1977. (Pubitemid 27318688)
14. Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. 2001. Toxoplasma gondii infection in United States: seroprevalence and risk factors. American Journal of Epidemiology 154:357-365. (Pubitemid 32756632)
15. Kang H, Remington JS, Suzuki Y. 2000. Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-g, TNF-a and inducible nitric oxide synthase. Journal of Immunology 164:2629-2634. (Pubitemid 30115494)
16. Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr. 2004. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry. Part B. Clinical Cytometry 61:35-39. (Pubitemid 39223368)
17. Kurtzhals JA, Reimert CM, Tette E, Dunyo SK, Koram KA, Akanmori BD et al. 1998. Increased eosinophil activity in acute Plasmodium falciparum infection-association with cerebral malaria. Clinical and Experimental Immunology 112:303-307. (Pubitemid 28266691)
18. Lappalainen M, Koskela P, Koskiniemi M, AmmäläP, Hiilesmaa V, Teramo K et al. 1993. Toxoplasmosis acquired during pregnancy: improved serodiagnosis based on avidity of IgG. Journal of Infectious Diseases 167:691-697. (Pubitemid 23056336)
19. Liesenfeld O, Montoya JG, Tathineni NJ, Davis M, Brown BW Jr, Cobb KL et al. 2001. Confirmatory serologic testing for acute toxoplasmosis and rate of induced abortions among women reported to have positive Toxoplasma immunoglobulin M antibody titers. American Journal of Obstetrics and Gynecology 184:140-145. (Pubitemid 32141656)
20. López-Osuna M, Arellano J, Kretschmer RR. 1992. The destruction of virulent Entamoeba histolytica by activated human eosinophils. Parasite Immunology 14:579-586.
21. Martins TB. 2002. Determination of cytokine responses using a multiplexed fluorescent microsphere immunoassay. American Journal of Clinical Pathology 118:346-353. (Pubitemid 37046332)
22. McCabe RE, Luft BJ, Remington JS. 1984. Effect of murine interferon gamma on murine toxoplasmosis. Journal of Infectious Diseases 150:961-962. (Pubitemid 15182158)
23. Montoya JG, Liesenfeld O. 2004. Toxoplasmosis. Lancet 363:1965-1976. (Pubitemid 38759657)
24. Nickdel MB, Lyons RE, Roberts F, Brombacher F, Hunter CA, Alexander J et al. 2004. Intestinal pathology during acute toxoplasmosis is IL-4 dependent and unrelated to parasite burden. Parasite Immunology 26:75-82. (Pubitemid 38916337)
25. Parker SJ, Roberts CW, Alexander J. 1991. CD8p T cells are the major lymphocyte subpopulation involved in the protective immune response to Toxoplasma gondii in mice. Clinical and Experimental Immunology 84:207-212.
26. Petersen E. 2007. Toxoplasmosis. Seminars in Fetal and Neonatal Medicine 12:214-223. (Pubitemid 46670815)
27. Romagnani S. 1996. Understanding the role of Th1/Th2 cells in infection. Trends in Microbiology 471:470-473. (Pubitemid 27013219)
28. Ruzicka K, Veitl M, Thalhammer-Scherrer R, Schwarzinger I. 2001. The New Hematology Analyzer Sysmex XE-2100 - performance evaluation of a novel white blood cell differential technology. Archives of Pathology and Laboratory Medicine 125:391-396. (Pubitemid 32207178)
29. Schulte C, Krebs B, Jelinek T, Nothdurft HD, von Sonnenburg F, Loscher T. 2002. Diagnostic significance of blood eosinophilia in returning travelers. Clinical Infectious Diseases 34:407-411. (Pubitemid 34062246)
30. Sensini A. 2006. Toxoplasma gondii infection in pregnancy: opportunities and pitfalls of serological diagnosis. Clinical Microbiology and Infection 12:504-512. (Pubitemid 43740761)
31. Sharma SD, Hofflin JM, Remington JS. 1985. In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii. Journal of Immunology 135:4160-4163. (Pubitemid 16250407)
32. Subauste CS, Koniaris AH, Remington JS. 1991. Murine CD8p cytotoxic T lymphocytes lyse Toxoplasma gondii-infected cells. Journal of Immunology 147:3955-3959.
33. Sukthana Y. 1999. Difference of Toxoplasma gondii antibodies between Thai and Austrian pregnant women. Southeast Asian Journal of Tropical Medicine and Public Health 30:38-41.
34. Suzuki Y, Orellana MA, Schreiber RD, Remington, JS. 1988. Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240:516-518.
35. Suzuki Y. 2002. Host resistance in the brain against Toxoplasma gondii. Journal of Infectious Diseases 185(Suppl 1):S58-S65. (Pubitemid 34142830)
36. Tenter AM, Heckeroth AR, Weiss LM. 2000. Toxoplasma gondii: from animals to humans. International Journal for Parasitology 30:1217-1258.
37. Villard O, Candolfi E, Despringre J, Derouin F, Marcellin L, Viville S et al. 1995. Protective effect of low doses of an anti-IL-4 monoclonal antibody in a murine model of acute toxoplasmosis. Parasite Immunology 17:233-236.
38. Wilson EH, Wille-Reece U, Dzierszinski F, Hunter CA. 2005. A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. Journal of Neuroimmunology 165:63-74. (Pubitemid 40984624)
39. Yan X, Zhong W, Tang A, Schielke EG, Hang W, Nolan JP. 2005. Multiplexed flow cytometric immunoassay for influenza virus detection and differentiation. Analytical Chemistry 77:7673-7678. (Pubitemid 41746235)
40. Yap G, PesinM, Sher A. 2000. Cutting edge: IL-12 is required for the maintenance of IFN-gamma production in T cells mediating chronic resistance to the intracellular pathogen, Toxoplasma gondii. Journal of Immunology 165:628-631. (Pubitemid 30484726)